Date: January 25th - 27th Location: San Diego, California Click here to register

Date: Thursday, March 2nd, 2023 Time: 1:00pm - 2:00pm ET Click here to register

Date: Monday, March 6th, 2023 Time: 1:30pm - 3:00pm ET Click here to register

Date: Wednesday, April 5, 2023 Time: 1:00pm - 2:00pm ET Click here to register

Date: Monday, April 17, 2023 Time: 1:00pm - 2:00pm ET Click here to register

Date: Thursday, June 15, 2023 Time: 1:30pm - 2:30pm ET TOPIC: Discover ALTUVIIIO™, A New Treatment Option for Your Patients, and the Customized Support Services Designed to Assist You OBJECTIVES: Read the full article...

Date: Thursday, June 29, 2023 Time: 2:00pm - 3:00pm ET TOPIC: Value Based Agreements with Payers OBJECTIVES: Takeda is excited to share more information about the transition from transactional relationships Read the full article...

Date: Thursday, July 13, 2023 Time: 2:00pm - 3:00pm ET TOPIC: Gene Therapy Update OBJECTIVES: Review the status of Roctavian and Hemgenix, gene therapy products and the Alliance contracts with the Read the full article...

Date: Tuesday, August 8, 2023 Time: 1:00pm - 2:00pm ET TITLE: HTC preparation for ROCTAVIAN ™ (valoctocogene roxaparvovec-rvox) OBJECTIVE: Learn about eligibility testing, ordering, storing, handling and administering ROCTAVIAN TARGET Read the full article...

Date: Tuesday, August 22, 2023 Time: 2:00pm - 3:00pm ET The webinar will review how to stay compliant with USP 797 SOP’s Training Competencies Task Management Reporting Alerting Elimination of Read the full article...

Date: Wednesday, September 20, 2023 Time: 1:00pm - 2:00pm ET TITLE: Case Discussion: Adult Severe Type 3 von Willebrand Disease Patient OBJECTIVE: In case you missed it at the National Read the full article...

Date: Wednesday, October 4, 2023 Time: 1:00pm - 2:00pm ET TITLE: An injectable, extended half-life recombinant, glycopegylated factor VIII concentrate for Hemophilia A OBJECTIVE: Provide a clinical overview of Esperoct Read the full article...

Date: Thursday, October 12, 2023 Time: 1:00pm - 2:00pm ET TITLE: A Label Update on Rebinyn, (Coagulation Factor IX (Recombinant), GlycoPEGylated: FDA Approval for a Prophylaxis Indication for Persons with Read the full article...

Date: Tuesday, October 24, 2023 Time: 2:00pm - 3:00pm ET TITLE: A Clinical Overview and Update from Sanofi for Efanesoctocog Alfa, A High Sustained Factor VIII Therapy OBJECTIVES: Highlighting both Read the full article...

Date: Tuesday, November 7, 2023 Time: 2:00pm - 3:00pm ET TITLE: Case Studies of Using BeneFix® (Coagulation Factor IX ) in Different Hemophilia B Patient Populations in an Evolving Treatment Read the full article...

Date: Thursday, November 9, 2023 Time: 1:00pm - 2:00pm ET TITLE: Learn More About Subcutaneous Prophylaxis Treatment for Hemophilia A: A Discussion on the Latest Data and Patient Management DESCRIPTION: Read the full article...

Date: Monday, November 13, 2023 Time: 1:00pm - 2:00pm ET TITLE: Hemgenix Real World Learnings SPEAKER: Vidhi Desai, MD Senior Medical Director, Coagulation North America Medical Affairs Vidhi Desai joined Read the full article...

Date: Friday, November 17, 2023 Time: 1:00pm - 2:00pm ET TOPIC: Clinical review of the Jivi® PROTECT VIII Trial and insights from HEM-POWR: A Real-World Evidence (RWE) Study of Jivi® Read the full article...

Date: Monday, November 27, 2023 Time: 1:00pm - 2:00pm ET TITLE: A different treatment option for Inhibitor patients OBJECTIVE: This presentation will provide an overview of inhibitors and explore the Read the full article...

Date: Wednesday, November 29, 2023 Time: 1:00pm - 2:00pm ET TITLE: Overview of Adzynma (rADAMTS13) Prescribing Information OBJECTIVE: Inform on the new approval and prescribing information of Adzynma indicated for Read the full article...